Stephen R. Spellman

19.5k total citations · 3 hit papers
265 papers, 9.2k citations indexed

About

Stephen R. Spellman is a scholar working on Hematology, Immunology and Transplantation. According to data from OpenAlex, Stephen R. Spellman has authored 265 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Hematology, 150 papers in Immunology and 62 papers in Transplantation. Recurrent topics in Stephen R. Spellman's work include Hematopoietic Stem Cell Transplantation (184 papers), T-cell and B-cell Immunology (102 papers) and Immune Cell Function and Interaction (95 papers). Stephen R. Spellman is often cited by papers focused on Hematopoietic Stem Cell Transplantation (184 papers), T-cell and B-cell Immunology (102 papers) and Immune Cell Function and Interaction (95 papers). Stephen R. Spellman collaborates with scholars based in United States, Germany and United Kingdom. Stephen R. Spellman's co-authors include Michael Haagenson, Mary M. Horowitz, Effie W. Petersdorf, Dennis L. Confer, Stephanie J. Lee, Tao Wang, Mary Eapen, John P. Klein, Martin Maiers and Carolyn Katovich Hurley and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Stephen R. Spellman

257 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

2007 886 citations Stephanie J. Lee, Michael Haagenson et al. Blood profile →
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry

2014 690 citations Loren Gragert, Mary Eapen et al. profile →
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

2017 473 citations R. Coleman Lindsley, Wael Saber et al. profile →

Peers

Countries citing papers authored by Stephen R. Spellman

Since Specialization

Citations

This map shows the geographic impact of Stephen R. Spellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen R. Spellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen R. Spellman more than expected).

Fields of papers citing papers by Stephen R. Spellman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen R. Spellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen R. Spellman. The network helps show where Stephen R. Spellman may publish in the future.

Co-authorship network of co-authors of Stephen R. Spellman

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen R. Spellman. A scholar is included among the top collaborators of Stephen R. Spellman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen R. Spellman. Stephen R. Spellman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide 2025 ·Blood Advances ·Dipenkumar Modi, Yosra Aljawai, Todd E. DeFor, Caitrin Bupp, Monzr M. Al Malki, Javier Bolaños‐Meade, Mahasweta Gooptu, Antonio Jiménez, Hongtao Liu, (unknown), Marco Mielcarek, Brian C. Shaffer, Bronwen E. Shaw, Stephen R. Spellman, Heather E. Stefanski, Jeffery J. Auletta, Steven M. Devine, Farhad Khimani, Ramzi Abboud	1
2	CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis 2024 ·Transplantation and Cellular Therapy ·A. Samer Al‐Homsi, Todd E. DeFor, (unknown), (unknown), Stephanie King, (unknown), George Yaghmour, (unknown), Caitrin Bupp, Stephen R. Spellman	1
3	The health risk of social disadvantage is transplantable into a new host 2024 ·Proceedings of the National Academy of Sciences ·Lucie M. Turcotte, (unknown), Kirsten Beyer, Steve W. Cole, Stephen R. Spellman, (unknown), Eric Williams, Yuhong Zhou, Michael R. Verneris, J. Douglas Rizzo, Jennifer M. Knight	2
4	Hemophagocytic Lymphohistiocytosis Gene Variants in Severe Aplastic Anemia and Their Impact on Hematopoietic Cell Transplantation Outcomes 2024 ·Transplantation and Cellular Therapy ·Maryam Rafati, Lisa J. McReynolds, Youjin Wang, Belynda Hicks, Kristine Jones, Stephen R. Spellman, (unknown), Yung‐Tsi Bolon, Esteban Arrieta‐Bolaños, Jennifer N. Saultz, Stephanie J. Lee, Sharon A. Savage, Shahinaz M. Gadalla	1
5	Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry 2024 ·Blood Advances ·Sara J. Schonfeld, Bryan Valcárcel, (unknown), Bronwen E. Shaw, Rachel Phelan, J. Douglas Rizzo, Ann Brunson, (unknown), Renata Abrahão, Ted Wun, Shahinaz M. Gadalla, Eric A. Engels, Paul S. Albert, Rafeek A. Yusuf, Stephen R. Spellman, Rochelle E. Curtis, Jeffery J. Auletta, Lori Muffly, Theresa H.M. Keegan, Lindsay M. Morton	0
6	Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes 2024 ·Transplantation and Cellular Therapy ·Yung‐Tsi Bolon, (unknown), (unknown), (unknown), Jeffery J. Auletta, Larisa Broglie, Rachel Cusatis, Kristin Page, Rachel Phelan, (unknown), Bronwen E. Shaw, (unknown), Patricia Steinert, Valerie Stewart, Cynthia Vierra‐Green, Stephanie J. Lee, Stephen R. Spellman	2
7	Interplay between donor age and HLA-DP matching in 10/10 HLA-matched unrelated donor HCT 2024 ·Blood Advances ·Rohtesh S. Mehta, Effie W. Petersdorf, Tao Wang, Stephen R. Spellman, Stephanie J. Lee	2
8	Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry 2023 ·Transplantation and Cellular Therapy ·Nancy Gillis, Eric Padron, Tao Wang, Karen Chen, (unknown), Stephen R. Spellman, Stephanie J. Lee, Carrie L. Kitko, Margaret L. MacMillan, Jeffrey West, (unknown), Mingxiang Teng, Samantha N. McNulty, Todd E. Druley, Joseph A. Pidala, Aleksandr Lazaryan	4
9	Persistence of FLT3-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission 2023 ·Blood ·(unknown), Georgia Andrew, Gege Gui, (unknown), Devdeep Mukherjee, Zoë C. Wong, Jeffery J. Auletta, Firas El Chaer, Adam Corner, Steven M. Devine, Antonio Jiménez, Marcos de Lima, Mark R. Litzow, Partow Kebriaei, Wael Saber, Stephen R. Spellman, Scott L. Zeger, Kristin Page, Laura W. Dillon, Christopher S. Hourigan	1
10	Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018 2023 ·Transplantation and Cellular Therapy ·Bryan Valcárcel, Sara J. Schonfeld, (unknown), Ann Brunson, (unknown), Renata Abrahão, Ted Wun, Jeffery J. Auletta, Shahinaz M. Gadalla, Eric A. Engels, Paul S. Albert, Stephen R. Spellman, J. Douglas Rizzo, Bronwen E. Shaw, Lori Muffly, Theresa H.M. Keegan, Lindsay M. Morton	3
11	How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy? 2023 ·Blood Reviews ·Mark Juckett, Christopher E. Dandoy, Zachariah DeFilipp, Tamila L. Kindwall‐Keller, Stephen R. Spellman, Celalettin Üstün, (unknown), Daniel J. Weisdorf, William A. Wood, Mary M. Horowitz, Linda J. Burns, Nandita Khera	1
12	Existence of HLA-Mismatched Unrelated Donors Closes the Gap in Donor Availability Regardless of Recipient Ancestry 2023 ·Transplantation and Cellular Therapy ·(unknown), Martin Maiers, Stephen R. Spellman, (unknown), Yung‐Tsi Bolon, Steven M. Devine	13
13	Cryopreservation of Allogeneic Hematopoietic Cell Grafts Did Not Adversely Impact Early Post-Transplant Survival during the First Six Months of the COVID-19 Pandemic 2022 ·Transplantation and Cellular Therapy ·Steven M. Devine, Michelle Kuxhausen, Stephen R. Spellman, Caitrin Bupp, Kwang Woo Ahn, Heather E. Stefanski, (unknown), Brent R. Logan, Bronwen E. Shaw	1
14	Race and Survival in Unrelated Hematopoietic Cell Transplantation 2022 ·Transplantation and Cellular Therapy ·Yasuo Morishima, Satoko Morishima, (unknown), Yoshihisa Kodera, Mary M. Horowitz, Caroline McKallor, Mari Malkki, Stephen R. Spellman, Ted Gooley, Effie W. Petersdorf	9
15	Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation 2021 ·Journal of Clinical Oncology ·Neema P. Mayor, Tao Wang, Stephanie J. Lee, Michelle Kuxhausen, Cynthia Vierra‐Green, Dominic J. Barker, Jeffery J. Auletta, Vijaya Raj Bhatt, Shahinaz M. Gadalla, Loren Gragert, Yoshihiro Inamoto, Gerald P. Morris, Sophie Paczesny, Ran Reshef, Olle Ringdén, Bronwen E. Shaw, Peter J. Shaw, Stephen R. Spellman, Steven G. E. Marsh	27
16	Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome 2020 ·Blood ·Mikko Myllymäki, Robert Redd, Christopher R. Reilly, Wael Saber, Stephen R. Spellman, Christopher J. Gibson, Zhen‐Huan Hu, Tao Wang, Esther H. Orr, (unknown), Maxine Chen, David P. Steensma, Corey Cutler, Immaculata De Vivo, Joseph H. Antin, Donna Neuberg, Suneet Agarwal, R. Coleman Lindsley	23
17	Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR 2019 ·Blood ·Jason Dehn, Stephen R. Spellman, Carolyn Katovich Hurley, Bronwen E. Shaw, Juliet N. Barker, Linda J. Burns, Dennis L. Confer, Mary Eapen, Marcelo Fernández-Viña, Robert J. Hartzman, Martin Maiers, Susana R. Marino, Carlheinz R. Mueller, Miguel‐Angel Perales, Raja Rajalingam, Joseph Pidala	173
18	Validation of a New Scrub typhus Rapid Kit-Standard Q Tsutsugamushi IgM/IgG 2019 ·SHILAP Revista de lepidopterología ·Stephen R. Spellman, (unknown), (unknown), (unknown)	0
19	Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis 2018 ·Biology of Blood and Marrow Transplantation ·Veronika Bachanová, Daniel J. Weisdorf, Tao Wang, Steven G. E. Marsh, Nezih Cereb, Michael Haagenson, Stephen R. Spellman, Stephanie J. Lee, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller, Sarah A. Cooley	8
20	Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells 2016 ·Cancer Research ·Dhifaf Sarhan, Frank Cichocki, Bin Zhang, Ashley Yingst, Stephen R. Spellman, Sarah Cooley, Michael R. Verneris, Bruce R. Blazar, Jeffrey S. Miller	157

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact